5EA
vs
D
1PK
5EA
Over the past 12 months, 5EA has significantly outperformed 1PK, delivering a return of +93% compared to the 1PK's 0% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
5EA
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Elanco Animal Health Inc
SWB:5EA
|
20.905
EUR
|
|||||
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
45.2
EUR
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
5EA, 1PK
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Elanco Animal Health Inc
Revenue
|
|||||||||||
|
D
|
Dechra Pharmaceuticals PLC
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
5EA, 1PK
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Elanco Animal Health Inc
SWB:5EA
|
|||||||||
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Elanco Animal Health Inc | ||||
|
D
|
Dechra Pharmaceuticals PLC | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Elanco Animal Health Inc | ||||
|
D
|
Dechra Pharmaceuticals PLC | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Elanco Animal Health Inc | ||||
|
D
|
Dechra Pharmaceuticals PLC | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Elanco Animal Health Inc | ||||
|
D
|
Dechra Pharmaceuticals PLC | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Elanco Animal Health Inc | ||||
|
D
|
Dechra Pharmaceuticals PLC | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Elanco Animal Health Inc | ||||
|
D
|
Dechra Pharmaceuticals PLC | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Elanco Animal Health Inc | ||||
|
D
|
Dechra Pharmaceuticals PLC | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
5EA, 1PK
Performance By Year
5EA, 1PK
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|